Ravi Shankar Akundi Selected Research

Ravi Shankar Akundi Research Topics

Disease

4	Neuroblastoma 09/2021 - 12/2003
3	Astrocytoma (Pilocytic Astrocytoma) 02/2006 - 07/2003
2	Neurodegenerative Diseases (Neurodegenerative Disease) 10/2021 - 08/2005
2	Inflammation (Inflammations) 10/2021 - 01/2014
2	Parkinson Disease (Parkinson's Disease) 11/2017 - 10/2004
2	Hypoxia (Hypoxemia) 01/2009 - 12/2006
2	Pain (Aches) 06/2006 - 04/2006
2	Encephalitis (Encephalitis, Rasmussen) 02/2006 - 08/2005
1	Rheumatoid Arthritis 10/2021
1	Machado-Joseph Disease (Spinocerebellar Ataxia Type 3) 07/2021
1	Neoplasm Metastasis (Metastasis) 01/2020
1	Neoplasms (Cancer) 01/2020
1	Neuroinflammatory Diseases 01/2014
1	Fever (Fevers) 06/2006
1	Migraine Disorders (Migraine) 04/2006
1	Traumatic Brain Injuries (Traumatic Brain Injury) 02/2006
1	Alzheimer Disease (Alzheimer's Disease) 02/2006
1	Brain Ischemia (Cerebral Ischemia) 02/2006
1	Chronic Disease (Chronic Diseases) 02/2006
1	Prion Diseases (Transmissible Spongiform Encephalopathies) 02/2006
1	Brain Diseases (Brain Disorder) 08/2005
1	Stroke (Strokes) 08/2005
1	Ischemia 08/2005
1	Mood Disorders (Mood Disorder) 07/2003

Drug/Important Bio-Agent (IBA)

3	Dinoprostone (PGE2)FDA Link 10/2021 - 02/2006
2	Prostaglandin-Endoperoxide Synthases (Cyclooxygenase)IBA 10/2021 - 01/2014
2	EnzymesIBA 10/2021 - 01/2014
2	Proteins (Proteins, Gene)FDA Link 01/2020 - 01/2009
2	Adenosine Triphosphate (ATP)IBA 01/2020 - 01/2014
2	1- Methyl- 4- phenyl- 1,2,3,6- tetrahydropyridine (MPTP)IBA 11/2017 - 10/2004
2	1- trichloromethyl- 1,2,3,4- tetrahydro- beta- carbolineIBA 11/2017 - 12/2003
2	Caffeine (No Doz)FDA LinkGeneric 12/2006 - 04/2006
2	ProstaglandinsIBA 06/2006 - 08/2005
2	Interleukin-6 (Interleukin 6)IBA 05/2005 - 07/2003
2	Caspase 3 (Caspase-3)IBA 10/2004 - 12/2003
1	Cyclooxygenase 2 Inhibitors (COX-2 Inhibitors)IBA 10/2021
1	Protein Isoforms (Isoforms)IBA 10/2021
1	Cholinesterase Inhibitors (Anticholinesterases)IBA 09/2021
1	Ataxin-3IBA 07/2021
1	polyglutamineIBA 07/2021
1	Cyclooxygenase 2 (Cyclooxygenase-2)IBA 01/2020
1	Non-Steroidal Anti-Inflammatory Agents (NSAIDs)IBA 01/2014
1	Oxygen (Dioxygen)IBA 12/2006
1	Purinergic P1 Receptors (Adenosine Receptor)IBA 12/2006
1	Adenosine (Adenocard)FDA LinkGeneric 12/2006
1	Cyclooxygenase 1IBA 06/2006
1	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 04/2006
1	Acetaminophen (Paracetamol)FDA LinkGeneric 04/2006
1	NF-kappa B (NF-kB)IBA 02/2006
1	Protein Kinase CIBA 02/2006
1	Prostaglandin E Receptors (Prostaglandin E Receptor)IBA 02/2006
1	Interleukin-1beta (Interleukin 1 beta)IBA 02/2006
1	CeramidesIBA 08/2005
1	Serotonin (5 Hydroxytryptamine)IBA 05/2005
1	p38 Mitogen-Activated Protein KinasesIBA 05/2005
1	Protein Kinase C-epsilonIBA 05/2005
1	Cytochromes c (Cytochrome c)IBA 10/2004
1	Trichloroethylene (Trichloroethene)IBA 10/2004
1	ManganeseIBA 10/2004
1	RotenoneIBA 10/2004
1	Chloral HydrateIBA 10/2004
1	Cytotoxins (Cytolysins)IBA 12/2003
1	Substance PIBA 07/2003
1	CytokinesIBA 07/2003
1	NeuropeptidesIBA 07/2003

Therapy/Procedure

1	Therapeutics 01/2020